Moreover, CAR+dex+IL-7-treated mice had superior survival, no tumor relapse, and were also the only treatment group to have CAR T cell presence in retro-orbital blood collection on day 25 (Figure 6B) and in the bone marrow at euthanasia on day 150 (Figure 6E). The gene discussed is IL7; the disease is neoplasm.